Subjective symptoms after treatment of early Lyme disease.

Elevated levels of IL-23 in a subset of patients with post-lyme disease symptoms following erythema migrans. Clin Infect Dis (2013) 3.36

Treatment trials for post-Lyme disease symptoms revisited. Am J Med (2013) 2.75

Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here? Qual Life Res (2013) 1.67

Physician reported incidence of early and late Lyme borreliosis. Parasit Vectors (2015) 1.62

Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease. Expert Rev Anti Infect Ther (2014) 1.48

Lyme neuroborreliosis-epidemiology, diagnosis and management. Nat Rev Neurol (2015) 0.91

Detection of Borrelia burgdorferi nucleic acids after antibiotic treatment does not confirm viability. J Clin Microbiol (2012) 0.87

Clinical characteristics associated with Borrelia burgdorferi sensu lato skin culture results in patients with erythema migrans. PLoS One (2013) 0.82

Gender disparity between cutaneous and non-cutaneous manifestations of Lyme borreliosis. PLoS One (2013) 0.82

Chronic Lyme disease. Infect Dis Clin North Am (2015) 0.82

Long-term Assessment of Post-Treatment Symptoms in Patients With Culture-Confirmed Early Lyme Disease. Clin Infect Dis (2015) 0.81

Prevalence and spectrum of residual symptoms in Lyme neuroborreliosis after pharmacological treatment: a systematic review. J Neurol (2015) 0.79

Correlation of Culture Positivity, PCR Positivity, and Burden of Borrelia burgdorferi Sensu Lato in Skin Samples of Erythema Migrans Patients with Clinical Findings. PLoS One (2015) 0.78

Lyme borreliosis. Nat Rev Dis Prim (2016) 0.78

Subjective health complaints are not associated with tick bites or antibodies to Borrelia burgdorferi sensu lato in blood donors in western Norway: a cross-sectional study. BMC Public Health (2015) 0.77

Doxycycline-mediated effects on persistent symptoms and systemic cytokine responses post-neuroborreliosis: a randomized, prospective, cross-over study. BMC Infect Dis (2012) 0.77

Quality of life, fatigue, depression and cognitive impairment in Lyme neuroborreliosis. J Neurol (2015) 0.76

Persistent symptoms following treatment of early Lyme disease: false hope? Am J Med (2010) 0.75

Symptom load and general function among patients with erythema migrans: a prospective study with a 1-year follow-up after antibiotic treatment in Norwegian general practice. Scand J Prim Health Care (2017) 0.75

Post-Lyme disease symptoms. Am J Med (2010) 0.75

Subjective symptoms after treatment of Lyme disease. Am J Med (2010) 0.75

Studies that report unexpected positive blood cultures for Lyme borrelia - are they valid? Diagn Microbiol Infect Dis (2017) 0.75

Cutaneous Lyme borreliosis: Guideline of the German Dermatology Society. Ger Med Sci (2017) 0.75

The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium. Arch Public Health (2017) 0.75

The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis (2006) 13.01

A critical appraisal of "chronic Lyme disease". N Engl J Med (2007) 7.84

Lyme borreliosis. Lancet (2011) 4.81

Diagnosis of lyme borreliosis. Clin Microbiol Rev (2005) 4.48

Differentiation of reinfection from relapse in recurrent Lyme disease. N Engl J Med (2012) 3.79

Lyme borreliosis. Lancet (2003) 3.75

Elevated levels of IL-23 in a subset of patients with post-lyme disease symptoms following erythema migrans. Clin Infect Dis (2013) 3.36

Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J Infect Dis (2003) 3.18

Antiscience and ethical concerns associated with advocacy of Lyme disease. Lancet Infect Dis (2011) 2.88

Common misconceptions about Lyme disease. Am J Med (2013) 2.84

Treatment trials for post-Lyme disease symptoms revisited. Am J Med (2013) 2.75

MLST of housekeeping genes captures geographic population structure and suggests a European origin of Borrelia burgdorferi. Proc Natl Acad Sci U S A (2008) 2.67

Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms. Brain Behav Immun (2010) 2.50

Southern Tick-Associated Rash Illness (STARI) in the North: STARI following a tick bite in Long Island, New York. Clin Infect Dis (2011) 2.19

Human Borrelia miyamotoi infection in the United States. N Engl J Med (2013) 2.11

Disease severity in a murine model of lyme borreliosis is associated with the genotype of the infecting Borrelia burgdorferi sensu stricto strain. J Infect Dis (2002) 1.97

Performance of United States serologic assays in the diagnosis of Lyme borreliosis acquired in Europe. Clin Infect Dis (2013) 1.82

The propensity of different Borrelia burgdorferi sensu stricto genotypes to cause disseminated infections in humans. Am J Trop Med Hyg (2008) 1.82

Reinfection in patients with Lyme disease. Clin Infect Dis (2007) 1.81

Efficacy of antibiotic prophylaxis for the prevention of Lyme disease: an updated systematic review and meta-analysis. J Antimicrob Chemother (2010) 1.75

Persistent and relapsing babesiosis in immunocompromised patients. Clin Infect Dis (2008) 1.71

Serologic markers of Lyme disease in children with autism. JAMA (2013) 1.67

Long-term follow-up of patients with culture-confirmed Lyme disease. Am J Med (2003) 1.62

Empiric antibiotic treatment of erythema migrans-like skin lesions as a function of geography: a clinical and cost effectiveness modeling study. Vector Borne Zoonotic Dis (2013) 1.59

Epidemiological aspects and molecular characterization of Borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. nov. Int J Med Microbiol (2007) 1.52

Chlorhexidine bathing to reduce central venous catheter-associated bloodstream infection: impact and sustainability. Am J Med (2012) 1.50

Single-dose prophylaxis against Lyme disease. Lancet Infect Dis (2007) 1.45

Analysis of sequences and loci of p44 homologs expressed by Anaplasma phagocytophila in acutely infected patients. J Clin Microbiol (2002) 1.45

Why has Borrelia burgdorferi not been transmitted by blood transfusion? Transfusion (2013) 1.42

Poly-ticks: Blue State versus Red State for Lyme disease. Lancet (2005) 1.42

Quantitative detection of Borrelia burgdorferi in 2-millimeter skin samples of erythema migrans lesions: correlation of results with clinical and laboratory findings. J Clin Microbiol (2002) 1.40

Comparative genome hybridization reveals substantial variation among clinical isolates of Borrelia burgdorferi sensu stricto with different pathogenic properties. J Bacteriol (2006) 1.34

Borrelia burgdorferi basic membrane proteins A and B participate in the genesis of Lyme arthritis. J Exp Med (2007) 1.29

Babesiosis in Lower Hudson Valley, New York, USA. Emerg Infect Dis (2011) 1.24

Natural history of colonization with vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and resistant gram-negative bacilli among long-term-care facility residents. Infect Control Hosp Epidemiol (2003) 1.24

In vitro susceptibility testing of Borrelia burgdorferi sensu lato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapy. Antimicrob Agents Chemother (2005) 1.23

Improving the yield of blood cultures from patients with early Lyme disease. J Clin Microbiol (2011) 1.22

Bartonella spp. transmission by ticks not established. Emerg Infect Dis (2010) 1.19

Epitope mapping of antibodies to VlsE protein of Borrelia burgdorferi in post-Lyme disease syndrome. Clin Immunol (2011) 1.18

Borrelia burgdorferi sensu stricto is clonal in patients with early Lyme borreliosis. Appl Environ Microbiol (2008) 1.16

2-tiered antibody testing for early and late Lyme disease using only an immunoglobulin G blot with the addition of a VlsE band as the second-tier test. Clin Infect Dis (2010) 1.15

Borrelia miyamotoi sensu lato seroreactivity and seroprevalence in the northeastern United States. Emerg Infect Dis (2014) 1.13

Validation of cultivation and PCR methods for diagnosis of Lyme neuroborreliosis. J Clin Microbiol (2008) 1.12

Seroprevalence of antibodies that react with Anaplasma phagocytophila, the agent of human granulocytic ehrlichiosis, in different populations in Westchester County, New York. J Clin Microbiol (2002) 1.11

A comparison of two treatment regimens of ceftriaxone in late Lyme disease. Wien Klin Wochenschr (2005) 1.10

Comparison of five diagnostic modalities for direct detection of Borrelia burgdorferi in patients with early Lyme disease. Diagn Microbiol Infect Dis (2012) 1.10

Anti-Borrelia burgdorferi antibody profile in post-Lyme disease syndrome. Clin Vaccine Immunol (2011) 1.09

Variations in Barbour-Stoenner-Kelly culture medium modulate infectivity and pathogenicity of Borrelia burgdorferi clinical isolates. Infect Immun (2004) 1.08

MonoMAC syndrome in a patient with a GATA2 mutation: case report and review of the literature. Clin Infect Dis (2013) 1.08

Multilocus sequence typing of Borrelia burgdorferi suggests existence of lineages with differential pathogenic properties in humans. PLoS One (2013) 1.07

Treatment of erythema migrans with doxycycline for 10 days versus 15 days. Clin Infect Dis (2012) 1.05

Suspected early Lyme neuroborreliosis in patients with erythema migrans. Clin Infect Dis (2013) 1.04

Quantitative detection of Borrelia burgdorferi sensu lato in erythema migrans skin lesions using internally controlled duplex real time PCR. PLoS One (2013) 1.02

Recombinant assay for serodiagnosis of Lyme disease regardless of OspA vaccination status. J Clin Microbiol (2002) 1.02

Borrelia burgdorferi stimulates macrophages to secrete higher levels of cytokines and chemokines than Borrelia afzelii or Borrelia garinii. J Infect Dis (2009) 1.01

The importance of tick-borne encephalitis virus RNA detection for early differential diagnosis of tick-borne encephalitis. J Clin Virol (2005) 1.01

Characterization of Borrelia burgdorferi sensu lato strains isolated from human material in Slovenia. Wien Klin Wochenschr (2002) 1.01

Biodiversity of Borrelia burgdorferi strains in tissues of Lyme disease patients. PLoS One (2011) 1.00

Lyme disease: European perspective. Infect Dis Clin North Am (2008) 1.00

A decline in C6 antibody titer occurs in successfully treated patients with culture-confirmed early localized or early disseminated Lyme Borreliosis. Clin Diagn Lab Immunol (2005) 0.99

Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis. Scand J Infect Dis (2005) 0.98

Lyme disease and human granulocytic anaplasmosis coinfection: impact of case definition on coinfection rates and illness severity. Clin Infect Dis (2012) 0.98

Erythromycin resistance in Borrelia burgdorferi. Antimicrob Agents Chemother (2002) 0.98

Tick-borne encephalitis in childhood--consensus 2004. Wien Med Wochenschr (2004) 0.94

Blood cultures for patients with extracutaneous manifestations of Lyme disease in the United States. Clin Infect Dis (2009) 0.94

Efficacy of short-course ceftriaxone therapy for Borrelia burgdorferi infection in C3H mice. Antimicrob Agents Chemother (2002) 0.94

Lyme borreliosis: a European perspective on diagnosis and clinical management. Curr Opin Infect Dis (2009) 0.93

A systematic review of Borrelia burgdorferi morphologic variants does not support a role in chronic Lyme disease. Clin Infect Dis (2013) 0.93

Comparison of erythema migrans caused by Borrelia burgdorferi and Borrelia garinii. Vector Borne Zoonotic Dis (2011) 0.92

Oral doxycycline for neuroborreliosis. Lancet Neurol (2008) 0.92

Double infection with tick borne encephalitis virus and Borrelia burgdorferi sensu lato. Wien Klin Wochenschr (2002) 0.91

Solitary borrelial lymphocytoma in adult patients. Wien Klin Wochenschr (2002) 0.91

Sensitivity of culture and polymerase chain reaction for the etiologic diagnosis of erythema migrans. Wien Klin Wochenschr (2002) 0.91

CTX-M β-lactamase-producing Klebsiella pneumoniae in suburban New York City, New York, USA. Emerg Infect Dis (2013) 0.91

Lyme borreliosis and Borrelia spielmanii. Emerg Infect Dis (2006) 0.91

Comparison of post-Lyme Borreliosis symptoms in erythema migrans patients with positive and negative Borrelia burgdorferi sensu lato skin culture. Vector Borne Zoonotic Dis (2010) 0.91

Utility of serodiagnostics designed for use in the United States for detection of Lyme borreliosis acquired in Europe and vice versa. Med Microbiol Immunol (2013) 0.91

Case report: severe neurological manifestation of Dobrava hantavirus infection. J Med Virol (2007) 0.90

Tick-borne encephalitis in Slovenia from 2000 to 2004: comparison of the course in adult and elderly patients. Wien Klin Wochenschr (2006) 0.90

Erythema migrans in solid-organ transplant recipients. Clin Infect Dis (2006) 0.90

Human granulocytic ehrlichiosis in Slovenia. Ann N Y Acad Sci (2003) 0.89

Comparison of patients fulfilling criteria for confirmed and probable human granulocytic ehrlichiosis. Scand J Infect Dis (2004) 0.89

Borrelia burgdorferi BmpA, BmpB, and BmpD proteins are expressed in human infection and contribute to P39 immunoblot reactivity in patients with Lyme disease. Clin Diagn Lab Immunol (2005) 0.89

Comparison of growth of Borrelia afzelii, B. garinii, and B. burgdorferi sensu stricto in MKP and BSK-II medium. Int J Med Microbiol (2004) 0.89

Hepatitis in association with rickettsialpox. Vector Borne Zoonotic Dis (2008) 0.89

Recognition and treatment of erythema migrans: are we off target? Ann Intern Med (2002) 0.88

Phylogeographic characterization of tick-borne encephalitis virus from patients, rodents and ticks in Slovenia. PLoS One (2012) 0.88

Vertical transmission of Babesia microti, United States. Emerg Infect Dis (2012) 0.88

Detection of Borrelia burgdorferi nucleic acids after antibiotic treatment does not confirm viability. J Clin Microbiol (2012) 0.87

Response to meta-analysis of Lyme borreliosis symptoms. Int J Epidemiol (2005) 0.87

Review: unraveling Lyme disease. Arthritis Rheumatol (2014) 0.87

Hemorrhagic fever with renal syndrome in the Pomurje region of Slovenia--an 18-year survey. Wien Klin Wochenschr (2005) 0.86